CNS Pharmaceuticals (CNSP) Short Interest Ratio & Short Volume $6.50 +0.23 (+3.59%) As of 09:58 AM Eastern This is a fair market value price provided by Polygon.io. Learn more. Add Compare Share Share Short Interest Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsFDA EventsHeadlinesInsider TradesOwnershipSEC FilingsShort InterestTrendsBuy This Stock CNS Pharmaceuticals Short Interest DataCNS Pharmaceuticals (CNSP) has a short interest of 40,500 shares, representing 7.71% of the float (the number of shares available for trading by the public). This marks a 29.81% increase in short interest from the previous month. The short interest ratio (days to cover) is 0.3, indicating that it would take 0.3 days of the average trading volume of 87,923 shares to cover all short positions.Current Short Interest40,500 sharesPrevious Short Interest31,200 sharesChange Vs. Previous Month+29.81%Dollar Volume Sold Short$323.19 thousandShort Interest Ratio0.3 Days to CoverLast Record DateJuly 31, 2025Outstanding Shares575,000 sharesFloat Size525,600 sharesShort Percent of Float7.71%Today's Trading Volume1,692 sharesAverage Trading Volume87,923 sharesToday's Volume Vs. Average2% Short Selling CNS Pharmaceuticals? Sign up to receive the latest short interest report for CNS Pharmaceuticals and its competitors with MarketBeat's FREE newsletter. Email Address Get Report View SMS TermsBy entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy. Skip Charts & View Short Interest HistoryShort Interest ChartDays to Cover ChartShort Percent of Float ChartCNSP Short Interest Over TimeCNSP Days to Cover Over TimeCNSP Percentage of Float Shorted Over Time CNS Pharmaceuticals Short Interest History Export to ExcelReport DateTotal Shares Sold ShortDollar Volume Sold ShortChange from Previous ReportPercentage of Float ShortedDays to CoverPrice on Report Date 7/31/202540,500 shares $323.19 thousand +29.8%7.7%0.3 $7.98 7/15/202531,200 shares $324.31 thousand -92.2%N/A0.2 $10.39 6/30/2025399,200 shares $329.34 thousand -13.4%7.4%0.2 $0.83 6/15/2025461,100 shares $372.25 thousand +153.4%8.5%0.3 $0.81 5/31/2025182,000 shares $190.19 thousand -75.1%3.4%0.1 $1.05 5/15/2025731,700 shares $921.94 thousand +16.2%13.5%0.4 $1.26 4/30/2025629,900 shares $683.44 thousand +94.5%21.6%1.3 $1.09 4/15/2025323,800 shares $309.88 thousand -4.4%11.1%0.6 $0.96 3/31/2025338,700 shares $460.63 thousand +88.1%11.6%0.5 $1.36 3/15/2025180,100 shares $561.91 thousand -32.9%6.2%0.3 $3.12 Get the Latest News and Ratings for CNSP and Related StocksEnter your email address below to receive the latest news and analysts' ratings for CNS Pharmaceuticals and its competitors with MarketBeat's FREE daily newsletter. 2/28/2025268,500 shares $652.46 thousand +241.6%9.9%0.5 $2.43 2/15/202578,600 shares $550.20 thousand -97.8%5.2%0.1 $7.00 1/31/20253,630,000 shares $345.21 thousand -19.9%N/A0.2 $0.10 1/15/20254,530,000 shares $498.30 thousand +861.6%N/A0.2 $0.11 12/31/2024471,100 shares $56.72 thousand -64.8%N/A0 $0.12 12/15/20241,340,000 shares $137.89 thousand -35.3%N/A0.1 $0.10 11/30/20242,070,000 shares $231.84 thousand +202.9%N/A0.1 $0.11 11/15/2024683,300 shares $71.81 thousand -40.1%N/A0 $0.11 10/31/20241,140,000 shares $127.22 thousand +2.7%N/A0.1 $0.11 10/15/20241,110,000 shares $137.86 thousand +63.5%N/A0.1 $0.12 9/30/2024679,000 shares $88.61 thousand +86.2%N/A0.1 $0.13 9/15/2024364,600 shares $54.03 thousand +80.1%N/A0.1 $0.15 8/31/2024202,500 shares $31.83 thousand +87.7%N/A0 $0.16 8/15/2024107,900 shares $15.21 thousand -90.3%N/A0 $0.14 7/31/20241,110,000 shares $351.65 thousand +314.3%40.1%0.3 $0.32 7/15/2024267,900 shares $316.12 thousand +229.9%9.7%0.2 $1.18 6/30/202481,200 shares $128.30 thousand +29.7%5.8%0.1 $1.58 6/15/202462,600 shares $174.65 thousand +1,465.0%27.3%0.2 $2.79 5/31/20244,000 shares $43.24 thousand -93.6%1.8%0.2 $10.81 5/15/202462,500 shares $12.01 thousand +100.3%0.6%0.2 $0.19 4/30/202431,200 shares $6.55 thousand +35.1%0.3%0.1 $0.21 4/15/202423,100 shares $5.53 thousand -53.8%0.2%0.1 $0.24 3/31/202450,000 shares $18.10 thousand -51.8%0.5%0.1 $0.36 3/15/2024103,800 shares $36.98 thousand +91.5%1.3%0.3 $0.36 2/29/202454,200 shares $15.07 thousand -47.2%0.7%0.1 $0.28 2/15/2024102,600 shares $29.04 thousand -87.2%1.3%0.3 $0.28 1/31/2024802,400 shares $199.00 thousand +317.1%10.2%2.6 $0.25 1/15/2024192,400 shares $179.89 thousand -10.8%3.1%1.6 $0.94 12/31/2023215,700 shares $273.94 thousand +298.0%3.5%2.1 $1.27 12/15/202354,200 shares $93.77 thousand +30.6%0.9%0.5 $1.73Musk’s Project Colossus could mint millionaires (Ad)I predict this single breakthrough could make Elon the world’s first trillionaire — and mint more new millionaires than any tech advance in history. And for a limited time, you have the chance to claim a stake in this project, even though it’s housed inside Elon’s private company, xAI.All the details are waiting for you now — but you need to act before the September 1st funding windo 11/30/202341,500 shares $86.32 thousand +75.1%0.8%0.6 $2.08 11/15/202323,700 shares $45.50 thousand -50.3%0.5%0.3 $1.92 10/31/202347,700 shares $98.74 thousand -36.6%1.2%0.3 $2.07 10/15/202375,200 shares $101.52 thousand +22.7%1.8%0.5 $1.35 9/30/202361,300 shares $69.88 thousand -8.5%1.5%0.5 $1.14 9/15/202367,000 shares $100.50 thousand -45.2%1.6%0.4 $1.50 8/31/2023122,300 shares $209.13 thousand +69.6%3.0%0.6 $1.71 8/15/202372,100 shares $123.29 thousand -3.1%1.8%0.2 $1.71 7/31/202374,400 shares $168.14 thousand +11.4%1.8%0.2 $2.26 7/15/202366,800 shares $142.95 thousand -70.0%1.6%0 $2.14 6/30/2023222,600 shares $496.40 thousand +7.2%5.5%0.1 $2.23 6/15/2023207,600 shares $448.42 thousand -9.4%5.1%0.1 $2.16 5/31/2023229,100 shares $421.54 thousand +91.6%5.7%0.1 $1.84 5/15/2023119,600 shares $166.24 thousand -44.6%3.0%0 $1.39 4/30/2023215,800 shares $325.86 thousand +306.4%10.0%0.1 $1.51 4/15/202353,100 shares $124.79 thousand +410.6%3.1%0 $2.35 3/31/202310,400 shares $10.40 thousand -57.6%0.6%0 $1.00 3/15/202324,500 shares $30.38 thousand +49.4%2.3%0.6 $1.24 2/28/202316,400 shares $30.34 thousand +62.4%1.6%0.4 $1.85 2/15/202310,100 shares $17.37 thousand +206.1%1.0%0.3 $1.72 1/31/20233,300 shares $7.29 thousand +153.9%0.3%0.1 $2.21 1/15/20231,300 shares $3.12 thousand -63.9%0.1%0.1 $2.40 12/30/20223,600 shares $8.64 thousand -65.4%0.3%0.2 $2.40 12/15/202210,400 shares $26.52 thousand -2.8%0.8%0.6 $2.55 11/30/202210,700 shares $32.42 thousand -88.5%1.1%0.7 $3.03 11/15/202293,200 shares $17.72 thousand +24.4%N/A0.5 $0.19 10/31/202274,900 shares $11.98 thousand +21.2%N/A0.4 $0.16 10/15/202261,800 shares $12.66 thousand -65.7%N/A0.3 $0.20 9/30/2022180,000 shares $32.22 thousand -14.6%N/A0.7 $0.18 9/15/2022210,800 shares $51.86 thousand +15.0%N/A0.4 $0.25 8/31/2022183,300 shares $44.80 thousand -1.6%N/A0.3 $0.24 8/15/2022186,200 shares $48.21 thousand +17.7%N/A0.3 $0.26 7/31/2022158,200 shares $34.76 thousand +870.6%N/A0.3 $0.22 7/15/202216,300 shares $4.40 thousand -95.0%N/A0 $0.27 6/30/2022325,800 shares $91.22 thousand +15.4%N/A0.4 $0.28 6/15/2022282,400 shares $77.01 thousand -46.6%N/A0.3 $0.27 5/31/2022528,500 shares $160.24 thousand +80.6%N/A0.6 $0.30 5/15/2022292,600 shares $84.85 thousand -19.7%N/A0.2 $0.29 4/30/2022364,500 shares $123.20 thousand -9.5%N/A0.2 $0.34 4/15/2022402,800 shares $157.09 thousand +1,154.8%N/A0.3 $0.39 3/31/202232,100 shares $10.95 thousand -89.0%N/A0 $0.34 3/15/2022291,000 shares $93.12 thousand -46.3%1.6%0.2 $0.32 2/28/2022541,900 shares $211.34 thousand +41.6%3.1%0.4 $0.39 2/15/2022382,700 shares $133.95 thousand -69.9%2.2%0.5 $0.35 1/31/20221,270,000 shares $763.27 thousand +8.6%7.2%1.7 $0.60 1/15/20221,170,000 shares $895.05 thousand +353.7%6.6%1.6 $0.77 12/31/2021257,900 shares $181.15 thousand +8.8%1.5%0.4 $0.70 12/15/2021237,000 shares $218.18 thousand -21.5%1.4%1.1 $0.92 11/30/2021301,800 shares $338.02 thousand +16.1%1.7%1.4 $1.12 11/15/2021260,000 shares $293.80 thousand -19.7%1.5%1.3 $1.13Musk’s Project Colossus could mint millionaires (Ad)I predict this single breakthrough could make Elon the world’s first trillionaire — and mint more new millionaires than any tech advance in history. And for a limited time, you have the chance to claim a stake in this project, even though it’s housed inside Elon’s private company, xAI.All the details are waiting for you now — but you need to act before the September 1st funding windo 10/29/2021323,900 shares $446.98 thousand -10.8%1.9%2.2 $1.38 10/15/2021363,200 shares $533.90 thousand -2.6%2.1%2.7 $1.47 9/30/2021373,000 shares $555.77 thousand -16.9%2.2%2.1 $1.49 9/15/2021448,700 shares $695.49 thousand +6.9%2.6%0.9 $1.55 8/31/2021419,600 shares $713.32 thousand 0.0%2.6%0.8 $1.70 8/13/2021419,700 shares $700.90 thousand -3.9%2.6%0.8 $1.67 7/30/2021436,900 shares $751.47 thousand -28.0%2.9%0.9 $1.72 7/15/2021607,000 shares $1.09 million +57.5%4.0%1.2 $1.80 6/30/2021385,400 shares $755.38 thousand +30.4%2.6%0.8 $1.96 6/15/2021295,600 shares $588.24 thousand +1.2%2.0%1.9 $1.99 5/28/2021292,100 shares $540.39 thousand -12.7%1.9%1.3 $1.85 5/14/2021334,400 shares $571.82 thousand +11.1%2.2%1.2 $1.71 4/30/2021300,900 shares $616.85 thousand -4.2%2.0%0.5 $2.05 4/15/2021314,100 shares $669.03 thousand -17.0%2.1%0.2 $2.13 3/31/2021378,400 shares $877.89 thousand -26.9%2.5%0.2 $2.32 3/15/2021517,400 shares $1.38 million -1.4%3.4%0.2 $2.67 2/26/2021524,900 shares $1.51 million +0.8%3.5%0.2 $2.88 2/12/2021520,600 shares $1.92 million +688.8%3.6%0.2 $3.68 1/29/202166,000 shares $119.46 thousand -53.2%0.5%0 $1.81 1/15/2021140,900 shares $264.89 thousand +13.7%1.0%0.1 $1.88 12/31/2020123,900 shares $219.30 thousand +89.7%0.9%0.1 $1.77 12/15/202065,300 shares $158.68 thousand -4.3%0.9%0.1 $2.43 11/30/202068,200 shares $163.68 thousand -15.0%1.0%1.4 $2.40 11/15/202080,200 shares $170.02 thousand +6.5%1.2%1.1 $2.12 10/30/202075,300 shares $134.79 thousand -1.3%1.2%0.8 $1.79 10/15/202076,300 shares $144.97 thousand -10.7%1.2%0.8 $1.90 9/30/202085,400 shares $150.30 thousand -5.6%1.3%0.8 $1.76 9/15/202090,500 shares $177.38 thousand -25.6%1.4%0.9 $1.96 8/31/2020121,700 shares $261.66 thousand +32.4%1.9%0.9 $2.15 CNSP Short Interest - Frequently Asked Questions What is CNS Pharmaceuticals' current short interest? Short interest is the volume of CNS Pharmaceuticals shares that have been sold short but have not yet been closed out or covered. As of July 31st, investors have sold 40,500 shares of CNSP short. 7.71% of CNS Pharmaceuticals' shares are currently sold short. Learn More on CNS Pharmaceuticals' current short interest. What is a good short interest percentage for CNS Pharmaceuticals? Companies that have a short interest as a percentage of float below 10% indicates positive investor sentiment and few short sellers. Stocks with a short interest percentage above 10% is considered high, suggesting some investors are pessimistic about the stock. Companies with a short interest percentage of 20% or more indicates widespread negative sentiment. 7.71% of CNS Pharmaceuticals' floating shares are currently sold short. Is CNS Pharmaceuticals' short interest increasing or decreasing? CNS Pharmaceuticals saw a increase in short interest in July. As of July 31st, there was short interest totaling 40,500 shares, an increase of 29.8% from the previous total of 31,200 shares. Changes in short volume can be used to identify positive and negative investor sentiment. Investors that short sell a stock are betting that its price will decline in the future. An increase in short sale volume suggests bearish (negative) sentiment among investors. A decrease on short sale volume suggests bullish (positive) sentiment. What is CNS Pharmaceuticals' float size? CNS Pharmaceuticals currently has issued a total of 575,000 shares. Some of CNS Pharmaceuticals' outstanding shares are available for trading, while others are subject to various restrictions. The public float, also referred to as floating shares or "the float", are shares that publicly owned, unrestricted and available to trade on the open market. CNS Pharmaceuticals currently has a public float of 525,600 shares. How does CNS Pharmaceuticals' short interest compare to its competitors? 7.71% of CNS Pharmaceuticals' shares are currently sold short. Here is how the short interest of companies in the industry of "pharmaceutical products" compare to CNS Pharmaceuticals: Soligenix Inc. (10.40%), Aptorum Group Limited (5.63%), Allarity Therapeutics, Inc. (4.92%), NextCure, Inc. (4.30%), ProPhase Labs, Inc. (0.36%), Bullfrog AI Holdings Inc. (4.40%), TherapeuticsMD, Inc. (0.18%), AlloVir, Inc. (2.56%), Leap Therapeutics, Inc. (4.98%), Flora Growth Corp. (1.16%), Which stocks are the most shorted right now? As of the most recent reporting period, the following stocks had the largest short interest positions: SPDR S&P 500 ETF Trust ($70.87 billion), Invesco QQQ ($30.12 billion), iShares Russell 2000 ETF ($19.85 billion), iShares 20+ Year Treasury Bond ETF ($10.34 billion), Strategy Inc ($8.98 billion), iShares iBoxx $ Investment Grade Corporate Bond ETF ($7.61 billion), SPDR S&P Biotech ETF ($6.81 billion), Invesco S&P 500 Equal Weight ETF ($6.14 billion), Palo Alto Networks, Inc. ($5.97 billion), and Super Micro Computer, Inc. ($5.28 billion). View all of the most shorted stocks. What does it mean to sell short CNS Pharmaceuticals stock? Short selling CNSP is an investing strategy that aims to generate trading profit from CNS Pharmaceuticals as its price is falling. CNSP shares are trading up $0.23 today. To short a stock, an investor borrows shares, sells them and buys the shares back on the public market later to return it to the lender. Short sellers are betting that a stock will decline in price. If the stock does drop after selling, the short seller buys it back at a lower price and returns it to the lender. The difference between the sell price and the buy price is the trader's profit. How does a short squeeze work against CNS Pharmaceuticals? A short squeeze for CNS Pharmaceuticals occurs when it has a large amount of short interest and its stock increases in price. This forces short sellers to cover their short interest positions by buying actual shares of CNSP, which in turn drives the price of the stock up even further. How often is CNS Pharmaceuticals' short interest reported? Short interest is typically published by a stock exchange once per month. However, NASDAQ publishes a report for U.S. stocks, including CNSP, twice per month. The most recent reporting period available is July, 31 2025. More Short Interest Resources from MarketBeat Related Companies Soligenix Short Interest Data Aptorum Group Short Interest Data Allarity Therapeutics Short Interest Data NextCure Short Interest Data ProPhase Labs Short Interest Data Bullfrog AI Short Interest Data TherapeuticsMD Short Interest Data AlloVir Short Interest Data Leap Therapeutics Short Interest Data Flora Growth Short Interest Data Short Interest Tools Stocks to Short Largest Short Interest Positions Short Interest Increases Short Interest Decreases Short Interest Reporting Dates This page (NASDAQ:CNSP) was last updated on 8/29/2025 by MarketBeat.com Staff From Our PartnersMusk’s Project Colossus could mint millionairesI predict this single breakthrough could make Elon the world’s first trillionaire — and mint more new milliona...Brownstone Research | SponsoredINVESTOR ALERT: Tiny “$3 AI Wonder Stock” on the Verge of Blasting OffRight now, we’re witnessing a monumental shift in the world.Traders Agency | SponsoredBONUS GUIDE - Ben Stein Prepares For the Next Financial CrisisWith inflation high, debt soaring, and global tensions rising, a financial storm may be brewing. Economist ...Goldco Precious Metals | SponsoredThis is my Christian duty“This land I will give to you…” — a 4,000-year-old line from Genesis may hold the key to unlocking a $150 tril...Paradigm Press | SponsoredEveryone’s watching Nvidia right now. Here’s why I’m excited.So, unless you’ve been living under a rock, you probably saw the news… Nvidia just signed a $7 BILLION deal...Timothy Sykes | SponsoredAlex’s “Next Magnificent Seven” stocksThe original “Magnificent Seven” turned $7K into $1.18 million. Now, Alex Green has identified AI’s Next Ma...The Oxford Club | SponsoredElon’s Secret Social Security BombshellTo All Americans Born Before April 16th, 1963: Did Trump Just Give The Green Light To Radically RE-DO Social S...Banyan Hill Publishing | SponsoredOut of 18,347 Cryptocurrencies... This is the ONLY OneThe Single Most Undervalued DeFi Protocol You've Never Heard Of If there's one cryptocurrency you should b...Crypto 101 Media | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added ten stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding CNS Pharmaceuticals, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share CNS Pharmaceuticals With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
MarketBeat All Access